Gary A. Koppel

Person

Indiannapolis, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
Beta-lactamylalkanoic acids for treating premenstrual disorders
- Patent number 9,597,314
- Issue date Mar 21, 2017
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
- Patent number 8,426,400
- Issue date Apr 23, 2013
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antag...
- Patent number 8,048,874
- Issue date Nov 1, 2011
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neurotherapeutic treatment for sexual dysfunction
- Patent number 7,998,991
- Issue date Aug 16, 2011
- Revaax Pharmaceuticals, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neurotherapeutic compositions and method
- Patent number 7,842,683
- Issue date Nov 30, 2010
- Revaax Pharmaceuticals, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral neurotherapeutic cephalosporin sulfoxide and sulfone-containin...
- Patent number 7,833,998
- Issue date Nov 16, 2010
- Revaax Pharmaceuticals, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
β-lactamyl vasopressin V1a antagonists
- Patent number 7,268,125
- Issue date Sep 11, 2007
- Azevan Pharmaceuticals, Inc.
- Robert F. Bruns, Jr.
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic treatment for sexual dysfunction
- Patent number 7,166,626
- Issue date Jan 23, 2007
- Revaax Pharmaceuticals, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
β-Lactamyl vasopressin V1a Antagonists
- Patent number 7,119,083
- Issue date Oct 10, 2006
- Azevan Pharmaceuticals, Inc.
- Robert F. Bruns, Jr.
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of behavioral disorders with β-lactam compounds
- Patent number 6,627,625
- Issue date Sep 30, 2003
- Revaax Pharmaceuticals, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-peptidyl vasopressin V1A antagonists
- Patent number 6,610,680
- Issue date Aug 26, 2003
- Eli Lilly and Company
- Robert F Bruns
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neurotherapeutic clavulanate composition and method
- Patent number 6,610,681
- Issue date Aug 26, 2003
- Revaax Pharmaceuticals, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-peptidyl vasopressin V1a antagonists
- Patent number 6,521,611
- Issue date Feb 18, 2003
- Eli Lilly and Company
- Robert F Bruns
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neurotherapeutic use of carboxypeptidase inhibitors
- Patent number 6,489,319
- Issue date Dec 3, 2002
- Revaax Pharmaceuticals, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of β-lactamase inhibitors as neuroprotectants
- Patent number 6,426,342
- Issue date Jul 30, 2002
- Revaax Pharmaceuticals, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-peptidyl vasopressin V1a antagonists
- Patent number 6,204,260
- Issue date Mar 20, 2001
- Eli Lilly and Company
- Robert F Bruns
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combinatorial process for synthesizing azetidinone analogs
- Patent number 5,759,865
- Issue date Jun 2, 1998
- Eli Lilly and Company
- Robert F. Bruns
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Cannabinoid receptor antagonists
- Patent number 5,747,524
- Issue date May 5, 1998
- Eli Lilly and Company
- George J. Cullinan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug-conjugates
- Patent number 5,665,358
- Issue date Sep 9, 1997
- Eli Lilly and Company
- Russell L. Barton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-drug conjugates
- Patent number 5,643,573
- Issue date Jul 1, 1997
- Eli Lilly and Company
- Russell L. Barton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cannabinoid receptor antagonists
- Patent number 5,596,106
- Issue date Jan 21, 1997
- Eli Lilly and Company
- George J. Cullinan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-drug conjugates
- Patent number 5,556,623
- Issue date Sep 17, 1996
- Eli Lilly and Company
- Russell L. Barton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cluster conjugates of drugs with antibodies
- Patent number 5,272,253
- Issue date Dec 21, 1993
- Eli Lilly and Company
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoglobulin conjugates
- Patent number 4,994,558
- Issue date Feb 19, 1991
- Eli Lilly and Company
- Henry K. Armour
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoglobulin conjugates of 2',2'-difluronucleosides
- Patent number 4,814,438
- Issue date Mar 21, 1989
- Eli Lilly and Company
- Henry K. Armour
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Furo[3,2-b]furan-2-(3H)-ones
- Patent number 4,552,895
- Issue date Nov 12, 1985
- Eli Lilly and Company
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ascorbic acid ethers in angiogene
- Patent number 4,552,888
- Issue date Nov 12, 1985
- Eli Lilly and Company
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for recovering 2-acetylthiomethyl-5-aminopentanoic acid
- Patent number 4,537,727
- Issue date Aug 27, 1985
- Eli Lilly and Company
- Russell L. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing 2-acetylthiomethyl-5-guanidinopentanoic acid
- Patent number 4,501,703
- Issue date Feb 26, 1985
- Eli Lilly and Company
- Russell L. Barton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for 4-(D-3-amino-3-carboxypropoxy)-phenylglyoxylic acid oxi...
- Patent number 4,355,172
- Issue date Oct 19, 1982
- Eli Lilly and Company
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION
- Publication number 20130131032
- Publication date May 23, 2013
- REVAAX PHARMACEUTICALS, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA-LACTAMYL PHENYLALANINE, CYSTEINE, AND SERINE VASOPRESSIN ANTAG...
- Publication number 20120220765
- Publication date Aug 30, 2012
- Gary A. KOPPEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION
- Publication number 20110257147
- Publication date Oct 20, 2011
- REVAAX PHARMACEUTICALS, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS
- Publication number 20110059935
- Publication date Mar 10, 2011
- Azevan Pharmaceuticals, Inc.
- Robert F. Bruns, JR.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Neurotherapeutic Cephalosporin Sulfoxide and Sulfone-Containing Com...
- Publication number 20110046103
- Publication date Feb 24, 2011
- REVAAX PHARMACEUTICALS, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUROTHERAPEUTIC COMPOSITION AND METHOD THEREFOR
- Publication number 20100249090
- Publication date Sep 30, 2010
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neurotherapeutic compositions
- Publication number 20100099656
- Publication date Apr 22, 2010
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA-LACTAM CANNABINOID RECEPTOR MODULATORS
- Publication number 20100016274
- Publication date Jan 21, 2010
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA-LACTAMYLALKANOIC ACIDS FOR TREATING PREMENSTRUAL DISORDERS
- Publication number 20090170825
- Publication date Jul 2, 2009
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Beta-Lactamyl Phenylalanine, Cysteine, and Serine Vasopressin Antag...
- Publication number 20080280870
- Publication date Nov 13, 2008
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Neurotherapeutic Compositions and Method
- Publication number 20080200447
- Publication date Aug 21, 2008
- REVAAX PHARMACEUTICALS, LLC
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oral Neurotherapeutic Cefazolin Compositons
- Publication number 20080176825
- Publication date Jul 24, 2008
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
{Beta}-Lactamyl vasopression V1a antagonists and methods of use
- Publication number 20080113959
- Publication date May 15, 2008
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
{Beta}-Lactamyl vasopression V1a antagonists and methods of use
- Publication number 20080090797
- Publication date Apr 17, 2008
- Azevan Pharmaceuticals, Inc.
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
[Beta]-Lactamyl Vasopressin V1a Antagonists and Methods of Use
- Publication number 20080033165
- Publication date Feb 7, 2008
- Gary A. Koppel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Neurotherapeutic composition and method therefor
- Publication number 20070249523
- Publication date Oct 25, 2007
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION
- Publication number 20070093466
- Publication date Apr 26, 2007
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-Substituted beta-lactamyl vasopressin v1a antagonists
- Publication number 20060281728
- Publication date Dec 14, 2006
- Christophe D.G. Guillon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Beta-lactamyl vasopressin V1a antagonists
- Publication number 20060217364
- Publication date Sep 28, 2006
- Robert F. Bruns
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Beta-lactamyl vasopressin v1aantagonists
- Publication number 20040266750
- Publication date Dec 30, 2004
- Robert F. Bruns Jr
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Neurotherapeutic composition and method
- Publication number 20040229857
- Publication date Nov 18, 2004
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibiotic composition and method
- Publication number 20040072815
- Publication date Apr 15, 2004
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neurotherapeutic clavulanate composition and method
- Publication number 20040014739
- Publication date Jan 22, 2004
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neurotherapeutic composition and method therefor
- Publication number 20030158172
- Publication date Aug 21, 2003
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Neurotherapeutic compositions
- Publication number 20020183304
- Publication date Dec 5, 2002
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Non-peptidyl vasopressin V1a antagonists
- Publication number 20020049187
- Publication date Apr 25, 2002
- Robert F. Bruns
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Neurotherapeutic use of carboxypeptidase inhibitors
- Publication number 20020028761
- Publication date Mar 7, 2002
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of beta-lactamase inhibitors as neuroprotectants
- Publication number 20020002159
- Publication date Jan 3, 2002
- Gary A. Koppel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Gary A. Koppel

Person

Patents Grantslast 30 patents

Beta-lactamylalkanoic acids for treating premenstrual disorders

β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists

Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antag...

Neurotherapeutic treatment for sexual dysfunction

Neurotherapeutic compositions and method

Oral neurotherapeutic cephalosporin sulfoxide and sulfone-containin...

β-lactamyl vasopressin V1a antagonists

Therapeutic treatment for sexual dysfunction

β-Lactamyl vasopressin V1a Antagonists

Treatment of behavioral disorders with &#x03B2;-lactam compounds

Non-peptidyl vasopressin V1A antagonists

Neurotherapeutic clavulanate composition and method

Non-peptidyl vasopressin V1a antagonists

Neurotherapeutic use of carboxypeptidase inhibitors

Use of &#x03B2;-lactamase inhibitors as neuroprotectants

Non-peptidyl vasopressin V1a antagonists

Combinatorial process for synthesizing azetidinone analogs

Cannabinoid receptor antagonists

Antibody drug-conjugates

Antibody-drug conjugates

Cannabinoid receptor antagonists

Antibody-drug conjugates

Cluster conjugates of drugs with antibodies

Immunoglobulin conjugates

Immunoglobulin conjugates of 2',2'-difluronucleosides

Furo[3,2-b]furan-2-(3H)-ones

Ascorbic acid ethers in angiogene

Process for recovering 2-acetylthiomethyl-5-aminopentanoic acid

Process for preparing 2-acetylthiomethyl-5-guanidinopentanoic acid

Process for 4-(D-3-amino-3-carboxypropoxy)-phenylglyoxylic acid oxi...

Patents Applicationslast 30 patents

NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION

BETA-LACTAMYL PHENYLALANINE, CYSTEINE, AND SERINE VASOPRESSIN ANTAG...

NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION

Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS

Neurotherapeutic Cephalosporin Sulfoxide and Sulfone-Containing Com...

NEUROTHERAPEUTIC COMPOSITION AND METHOD THEREFOR

Neurotherapeutic compositions

BETA-LACTAM CANNABINOID RECEPTOR MODULATORS

BETA-LACTAMYLALKANOIC ACIDS FOR TREATING PREMENSTRUAL DISORDERS

Beta-Lactamyl Phenylalanine, Cysteine, and Serine Vasopressin Antag...

Neurotherapeutic Compositions and Method

Oral Neurotherapeutic Cefazolin Compositons

{Beta}-Lactamyl vasopression V1a antagonists and methods of use

{Beta}-Lactamyl vasopression V1a antagonists and methods of use

[Beta]-Lactamyl Vasopressin V1a Antagonists and Methods of Use

Neurotherapeutic composition and method therefor

NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION

3-Substituted beta-lactamyl vasopressin v1a antagonists

Beta-lactamyl vasopressin V1a antagonists

Beta-lactamyl vasopressin v1aantagonists

Neurotherapeutic composition and method

Antibiotic composition and method

Neurotherapeutic clavulanate composition and method

Neurotherapeutic composition and method therefor

Neurotherapeutic compositions

Non-peptidyl vasopressin V1a antagonists

Neurotherapeutic use of carboxypeptidase inhibitors

Use of beta-lactamase inhibitors as neuroprotectants

Treatment of behavioral disorders with β-lactam compounds

Use of β-lactamase inhibitors as neuroprotectants